2KNOWHealth LLC – Trademark Portfolio
Entity Type: 16
2KNOWHealth LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 12 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ADOH and ADOH SCIENTIFIC. The owner is based in Mount Pleasant, SC.
Mount Pleasant, SC 29464
Showing of trademarks Trademarks
Trademark Classifications
2KNOWHealth LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does 2KNOWHealth LLC have?
2KNOWHealth LLC has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 abandoned.
What trademark classes does 2KNOWHealth LLC file in?
2KNOWHealth LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are 2KNOWHealth LLC's most well-known trademarks?
2KNOWHealth LLC's registered trademark portfolio includes well-known marks such as ADOH and ADOH SCIENTIFIC. These are among 2 currently registered trademarks in the portfolio.
What is 2KNOWHealth LLC's trademark registration success rate?
2KNOWHealth LLC has a 17% trademark registration rate, with 2 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.